Navigation Links
AACR colorectal cancer conference to focus on screening, new treatments
Date:10/21/2010

PHILADELPHIA The American Association for Cancer Research will hosts its first special conference on Colorectal Cancer: Biology to Therapy from Oct. 27-30, 2010, at the Loews Hotel, Philadelphia.

Colorectal cancer is the third leading cause of cancer in men and women. While screening has brought mortality rates down, much work remains to be done.

"Colorectal cancer is still one of the deadliest cancers, and our current screening methods are not yet always efficient or complete," said Anil Rustgi, M.D., chief of gastroenterology, T. Grier Miller Professor of Medicine and Genetics, and American Cancer Society Professor at the University of Pennsylvania School of Medicine and a program chairperson of the AACR special conference.

Rustgi will host a press conference on Thursday, Oct. 28 at 1:00 p.m. ET in the Adams Room on the third floor of the Loews Hotel in Philadelphia. The press conference will feature the following new research:

  • Telomere Length Affects Colorectal Cancer Risk
  • New Colorectal Screening Test Measures DNA Methylation
  • FAK Inhibitor Effectively Blocked Colon Cancer Cell Growth and Viability
  • Jekyll-Hyde MicroRNA Binding Variant Linked to Improved Outcome in Early-stage Colorectal Cancer

Reporters who cannot attend in person can participate using the following information:

Dial-in (U.S. and Canada): (888) 282-7404
Dial-in (International): (706) 679-5207
Access Code: 18304706

The American Association for Cancer Research Communications Department has also identified the following research as newsworthy:

  • Researchers Build Colony of Colon Cancer Stem Cells to Test New Approach to Therapy
  • Small-molecule Inhibitors Effectively Targeted Active Colon Cancer Enzyme


'/>"/>

Contact: Jeremy Moore
jeremy.moore@aacr.org
267-646-0557
American Association for Cancer Research
Source:Eurekalert

Page: 1

Related biology news :

1. Hormone therapy associated with reduced colorectal cancer risk
2. Rural areas able to increase screening capacity for colorectal cancer
3. Study finds colorectal cancer rates increasing worldwide
4. Colorectal cancer
5. Cigarette smoking increases colorectal cancer risk
6. Breast cancer treatment resistance linked to signaling pathway
7. Jefferson scientists deliver toxic genes to effectively kill pancreatic cancer cells
8. The dietary supplement genistein can undermine breast cancer treatment
9. Saliva proteins could help detection of oral cancer
10. Vitamin C supplements may reduce benefit from wide range of anti-cancer drugs
11. Breakthrough optical technology to assess colon cancer risk, accuracy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/4/2017)... , April 4, 2017   EyeLock LLC ... announced that the United States Patent and Trademark Office ... broadly covers the linking of an iris image with ... transaction) and represents the company,s 45 th issued ... patent is very timely given the multi-modal biometric capabilities ...
(Date:3/30/2017)... The research team of The Hong Kong Polytechnic University (PolyU) ... ground breaking 3D fingerprint minutiae recovery and matching technology, pushing contactless ... use in identification, crime investigation, immigration control, security of access and ... ... A research team led by Dr Ajay Kumar ...
(Date:3/28/2017)... , March 28, 2017 ... Biometrics), Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video ... and Region - Global Forecast to 2022", published by ... in 2016 and is projected to reach USD 75.64 ... 2017 and 2022. The base year considered for the ...
Breaking Biology News(10 mins):
(Date:8/17/2017)... Coral Springs, FL (PRWEB) , ... August 17, ... ... today announced that the stock market news outlet had provided a research update ... the company's nasally administered TRT product. , According to Soulstring, prescription rates for ...
(Date:8/16/2017)... Ca (PRWEB) , ... August 16, 2017 , ... ... by changing into a different cell type. Many treatments for specific cancers, such ... prominent example of targeted treatment is androgen deprivation therapy for advanced prostate cancer. ...
(Date:8/16/2017)... 2017  This year,s edition of the Inc. 5000 features a now-familiar ... solutions, has made the list for the third year in a row. ... private companies based on a set of quantitative metrics. In addition, BioPoint ... companies in the Bay State . ... Inc. 5000 ...
(Date:8/15/2017)... ... August 15, 2017 , ... Nanomedical ... and biotherapeutics development, announces the launch of the new NHS Agile biosensor ... kinetic binding data for a wide range of molecules, including small and large ...
Breaking Biology Technology: